Cellect Biotechnology Ltd. (APOP) announced Monday morning that the first stem cell transplant procedure has been successfully performed using its ApoGraft technology in its Phase I/II clinical trial in a blood cancer patient.
from RTT - Before the Bell http://ift.tt/2nrmco2
via IFTTT
No comments:
Post a Comment